U.S. Stem Cell, Inc. (USRM)
OTCMKTS: USRM · Delayed Price · USD
0.0001
0.00 (0.00%)
Apr 24, 2024, 3:46 PM EDT - Market closed

U.S. Stem Cell Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2002
Net Income
-3.31-4.29-3.38-5.04-2.16-3.48-2.07-1.64-2.25-3.14
Upgrade
Depreciation & Amortization
0.690.980.450.240.210.180.010.0100
Upgrade
Share-Based Compensation
0.380.560.70.8200.650.411.150.540.13
Upgrade
Other Operating Activities
1.931.71.752.762.563.891.77-0.360.61.1
Upgrade
Operating Cash Flow
-0.3-1.06-0.48-1.210.61.230.11-0.84-1.11-1.91
Upgrade
Operating Cash Flow Growth
-----51.07%997.09%----
Upgrade
Capital Expenditures
000-0.170-0-0.01-0-0.01-0.01
Upgrade
Acquisitions
0000.170.310.230000
Upgrade
Change in Investments
----0.15-0.12-0.23-0.18-0.01-0.05-
Upgrade
Other Investing Activities
---0.320.120.730.34-0.22--
Upgrade
Investing Cash Flow
0000.170.310.720.16-0.23-0.06-0.01
Upgrade
Common Stock Issued
0.090.2800.050.370.280.060.580.481.43
Upgrade
Share Repurchases
000000-0-000
Upgrade
Other Financing Activities
0.190.80.5-0.36-0.91-1.51-0.120.520.680.54
Upgrade
Financing Cash Flow
0.271.080.5-0.31-0.54-1.24-0.051.11.161.97
Upgrade
Net Cash Flow
-0.030.020.02-1.360.370.720.210.02-0.010.05
Upgrade
Free Cash Flow
-0.3-1.06-0.48-1.380.61.230.1-0.85-1.12-1.92
Upgrade
Free Cash Flow Growth
-----51.03%1134.43%----
Upgrade
Free Cash Flow Margin
-371.55%-527.00%-172.83%-44.85%8.99%22.28%3.23%-38.64%-54.32%-2001.09%
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.000.000.000.00-0.93-2.29-7.64
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.